{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:14:35Z","timestamp":1684469675025},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1038\/ncpuro0517","type":"journal-article","created":{"date-parts":[[2006,8,11]],"date-time":"2006-08-11T09:50:43Z","timestamp":1155289843000},"page":"398-399","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of high-risk, non-muscle-invasive bladder cancer"],"prefix":"10.1038","volume":"3","author":[{"given":"Seth P","family":"Lerner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpuro0517_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0302-2838(01)00026-4","volume":"41","author":"W Oosterlinck","year":"2002","unstructured":"Oosterlinck W  et al. (2002) Guidelines on bladder cancer. Eur Urol 41:105\u2013112","journal-title":"Eur Urol"},{"key":"BFncpuro0517_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0022-5347(05)67975-X","volume":"163","author":"F Millan-Rodriguez","year":"2000","unstructured":"Millan-Rodriguez F  et al. (2000) Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163: 73\u201378","journal-title":"J Urol"},{"key":"BFncpuro0517_CR3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1200\/JCO.1998.16.3.1099","volume":"16","author":"HW Herr","year":"1998","unstructured":"Herr HW (1998) Extravesical tumor relapse in patients with superficial bladder tumors. J Clin Oncol 16: 1099\u20131102","journal-title":"J Clin Oncol"},{"key":"BFncpuro0517_CR4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","volume":"163","author":"DL Lamm","year":"2000","unstructured":"Lamm DL  et al. (2000) Maintenance bacillus Calmette\u2013Gu\u00e9rin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163: 1124\u20131129","journal-title":"J Urol"},{"key":"BFncpuro0517_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.urolonc.2005.05.005","volume":"23","author":"SP Lerner","year":"2005","unstructured":"Lerner SP (2005) Bladder cancer clinical trials. Urol Oncol 23: 275\u2013279","journal-title":"Urol Oncol"},{"key":"BFncpuro0517_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0022-5347(01)62517-5","volume":"160","author":"CP Dinney","year":"1998","unstructured":"Dinney CP  et al. (1998) Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. J Urol 160: 1285\u20131290","journal-title":"J Urol"},{"key":"BFncpuro0517_CR7","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/01.ju.0000136446.37840.0a","volume":"172","author":"MA O'Donnell","year":"2004","unstructured":"O'Donnell MA  et al. (2004) Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer. J Urol 172: 888\u2013893","journal-title":"J Urol"},{"key":"BFncpuro0517_CR8","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1200\/JCO.2002.02.066","volume":"20","author":"G Dalbagni","year":"2002","unstructured":"Dalbagni G  et al. (2002) Phase I trial of intravesical gemcitabine in bacillus Calmette\u2014Gu\u00e9rin-refractory transitional-cell carcinoma of the bladder. J Clin Oncol 20: 3193\u20133198","journal-title":"J Clin Oncol"},{"key":"BFncpuro0517_CR9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.urology.2005.04.062","volume":"66","author":"R Bartoletti","year":"2005","unstructured":"Bartoletti R  et al. (2005) Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a phase II prospective multicenter study. Urology 66: 726\u2013731","journal-title":"Urology"},{"key":"BFncpuro0517_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.eururo.2004.01.019","volume":"46","author":"AG van der Heijden","year":"2004","unstructured":"van der Heijden AG  et al. (2004) Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol 46: 65\u201371","journal-title":"Eur Urol"}],"container-title":["Nature Clinical Practice Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0517","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:11:17Z","timestamp":1684440677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpuro0517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["BFncpuro0517"],"URL":"https:\/\/doi.org\/10.1038\/ncpuro0517","relation":{},"ISSN":["1743-4270","1743-4289"],"issn-type":[{"value":"1743-4270","type":"print"},{"value":"1743-4289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}